OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 69 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,803,928 | +129.9% | 388,982 | +68.1% | 0.01% | +120.0% |
| Q2 2023 | $2,089,840 | +43.4% | 231,433 | -44.9% | 0.01% | +66.7% |
| Q1 2023 | $1,457,400 | +41.6% | 420,000 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $1,029,000 | -11.2% | 420,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $1,159,000 | -43.0% | 420,000 | -16.0% | 0.00% | -40.0% |
| Q2 2022 | $2,035,000 | +438.4% | 500,000 | +463.1% | 0.01% | +400.0% |
| Q1 2022 | $378,000 | -94.0% | 88,797 | -60.5% | 0.00% | -91.7% |
| Q2 2021 | $6,296,000 | – | 225,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |